vs
APOGEE ENTERPRISES, INC.（APOG）とAVANOS MEDICAL, INC.（AVNS）の財務データ比較。上の社名をクリックして会社を切り替えられます
APOGEE ENTERPRISES, INC.の直近四半期売上が大きい（$351.4M vs $180.9M、AVANOS MEDICAL, INC.の約1.9倍）。APOGEE ENTERPRISES, INC.の純利益率が高く（4.7% vs -0.7%、差は5.4%）。APOGEE ENTERPRISES, INC.の前年同期比売上増加率が高い（1.6% vs 0.7%）。過去8四半期でAVANOS MEDICAL, INC.の売上複合成長率が高い（4.4% vs 2.9%）
Apogee Enterprisesはアメリカのオーディオ機器メーカーです。オーディオインターフェース、AD/DAコンバーター、USB・iOS対応マイクの製造を主軸に、オーディオ制作向けソフトウェアの開発も手がけており、プロの録音や音楽制作分野で広く利用されています。
Avanos Medicalは医療テクノロジー企業で、臨床医療機器の開発・製造に注力しており、疼痛管理と慢性ケアの2つのコア事業を展開しています。患者の回復促進や感染予防に取り組みながら、治療におけるオピオイド系薬剤の使用削減を目指しています。
APOG vs AVNS — 直接比較
損益計算書 — Q4 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $351.4M | $180.9M |
| 純利益 | $16.6M | $-1.3M |
| 粗利率 | 22.4% | 47.5% |
| 営業利益率 | 7.3% | 1.4% |
| 純利益率 | 4.7% | -0.7% |
| 売上前年比 | 1.6% | 0.7% |
| 純利益前年比 | 568.8% | 99.7% |
| EPS（希薄化後） | $0.78 | $-0.02 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $180.9M | ||
| Q3 25 | $358.2M | $177.8M | ||
| Q2 25 | $346.6M | $175.0M | ||
| Q1 25 | $345.7M | $167.5M | ||
| Q4 24 | $341.3M | $179.6M | ||
| Q3 24 | $342.4M | $170.4M | ||
| Q2 24 | $331.5M | $171.7M |
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | $-1.3M | ||
| Q3 25 | $23.6M | $-1.4M | ||
| Q2 25 | $-2.7M | $-76.8M | ||
| Q1 25 | $2.5M | $6.6M | ||
| Q4 24 | $21.0M | $-397.3M | ||
| Q3 24 | $30.6M | $4.3M | ||
| Q2 24 | $31.0M | $1.8M |
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | 47.5% | ||
| Q3 25 | 23.1% | 48.4% | ||
| Q2 25 | 21.7% | 52.6% | ||
| Q1 25 | 21.6% | 53.6% | ||
| Q4 24 | 26.1% | 54.6% | ||
| Q3 24 | 28.4% | 54.5% | ||
| Q2 24 | 29.8% | 55.7% |
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | 1.4% | ||
| Q3 25 | 7.5% | 0.1% | ||
| Q2 25 | 2.0% | -42.6% | ||
| Q1 25 | 1.8% | 6.1% | ||
| Q4 24 | 8.4% | -233.0% | ||
| Q3 24 | 12.3% | 7.0% | ||
| Q2 24 | 12.5% | 3.7% |
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | -0.7% | ||
| Q3 25 | 6.6% | -0.8% | ||
| Q2 25 | -0.8% | -43.9% | ||
| Q1 25 | 0.7% | 3.9% | ||
| Q4 24 | 6.1% | -221.2% | ||
| Q3 24 | 8.9% | 2.5% | ||
| Q2 24 | 9.4% | 1.0% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | $-0.02 | ||
| Q3 25 | $1.10 | $-0.03 | ||
| Q2 25 | $-0.13 | $-1.66 | ||
| Q1 25 | $0.12 | $0.14 | ||
| Q4 24 | $0.96 | $-8.64 | ||
| Q3 24 | $1.40 | $0.09 | ||
| Q2 24 | $1.41 | $0.04 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $39.5M | $89.8M |
| 総負債低いほど良い | $232.3M | $90.3M |
| 株主資本純資産 | $511.8M | $778.2M |
| 総資産 | $1.1B | $1.1B |
| 負債/資本比率低いほどレバレッジが低い | 0.45× | 0.12× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $89.8M | ||
| Q3 25 | $39.5M | $70.5M | ||
| Q2 25 | $32.8M | $90.3M | ||
| Q1 25 | $41.4M | $97.0M | ||
| Q4 24 | $43.9M | $107.7M | ||
| Q3 24 | $51.0M | $89.0M | ||
| Q2 24 | $30.4M | $92.2M |
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | $90.3M | ||
| Q3 25 | — | $93.4M | ||
| Q2 25 | — | $95.7M | ||
| Q1 25 | $285.0M | $98.0M | ||
| Q4 24 | — | $125.3M | ||
| Q3 24 | — | $152.6M | ||
| Q2 24 | — | $164.9M |
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $778.2M | ||
| Q3 25 | $500.2M | $778.0M | ||
| Q2 25 | $481.8M | $776.3M | ||
| Q1 25 | $487.9M | $839.4M | ||
| Q4 24 | $522.1M | $828.5M | ||
| Q3 24 | $506.4M | $1.2B | ||
| Q2 24 | $480.0M | $1.2B |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.2B | $1.1B | ||
| Q2 25 | $1.2B | $1.0B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $917.1M | $1.7B | ||
| Q2 24 | $889.0M | $1.7B |
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.12× | ||
| Q1 25 | 0.58× | 0.12× | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.13× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $122.5M | $28.2M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $21.3M |
| FCFマージンFCF / 売上 | — | 11.8% |
| 設備投資強度設備投資 / 売上 | 7.8% | 3.8% |
| キャッシュ転換率営業CF / 純利益 | 7.37× | — |
| 直近12ヶ月FCF直近4四半期 | — | $43.1M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $28.2M | ||
| Q3 25 | $57.1M | $14.0M | ||
| Q2 25 | $-19.8M | $6.8M | ||
| Q1 25 | $30.0M | $25.7M | ||
| Q4 24 | $31.0M | $57.9M | ||
| Q3 24 | $58.7M | $23.0M | ||
| Q2 24 | $5.5M | $27.8M |
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | $21.3M | ||
| Q3 25 | $52.4M | $7.0M | ||
| Q2 25 | $-26.9M | $-4.2M | ||
| Q1 25 | $19.1M | $19.0M | ||
| Q4 24 | $22.0M | $53.1M | ||
| Q3 24 | $50.2M | $20.0M | ||
| Q2 24 | $-1.8M | $21.9M |
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | 11.8% | ||
| Q3 25 | 14.6% | 3.9% | ||
| Q2 25 | -7.8% | -2.4% | ||
| Q1 25 | 5.5% | 11.3% | ||
| Q4 24 | 6.4% | 29.6% | ||
| Q3 24 | 14.7% | 11.7% | ||
| Q2 24 | -0.5% | 12.8% |
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | 3.8% | ||
| Q3 25 | 1.3% | 3.9% | ||
| Q2 25 | 2.1% | 6.3% | ||
| Q1 25 | 3.2% | 4.0% | ||
| Q4 24 | 2.6% | 2.7% | ||
| Q3 24 | 2.5% | 1.8% | ||
| Q2 24 | 2.2% | 3.4% |
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.08× | 3.89× | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.92× | 5.35× | ||
| Q2 24 | 0.18× | 15.44× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
